These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7542272)

  • 1. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
    Pawlotsky JM; Roudot-Thoraval F; Pellet C; Aumont P; Darthuy F; Remire J; Duval J; Dhumeaux D
    J Clin Microbiol; 1995 May; 33(5):1357-9. PubMed ID: 7542272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
    Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
    Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease.
    Ichimura H; Tamura I; Kurimura O; Koda T; Mizui M; Tsuchie H; Kurimura T
    J Med Virol; 1994 Jul; 43(3):212-5. PubMed ID: 7523579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
    Pawlotsky JM; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
    J Clin Microbiol; 1996 Jan; 34(1):80-3. PubMed ID: 8748278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes.
    Yuki N; Hayashi N; Mita E; Hagiwara H; Oshita M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Feb; 45(2):162-7. PubMed ID: 7539828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types.
    Tisminetzky S; Gerotto M; Pontisso P; Chemello L; Prescott LE; Rose KA; Baralle F; Simmonds P; Alberti A
    J Virol Methods; 1995 Nov; 55(3):303-7. PubMed ID: 8609196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States.
    Zein NN; Rakela J; Persing DH
    Mayo Clin Proc; 1995 May; 70(5):449-52. PubMed ID: 7537347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological responses to different genotypes of hepatitis C virus in France.
    Alonso C; Qu D; Lamelin JP; de Sanjosé S; Vitvitski L; Li J; Berby F; Lambert V; Cortey ML; Trépo C
    J Clin Microbiol; 1994 Jan; 32(1):211-2. PubMed ID: 7510309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen.
    Lavanchy D; Mayerat C; Morel B; Schneider P; Zufferey C; Gonvers JJ; Pécoud A; Frei PC
    J Clin Microbiol; 1994 Sep; 32(9):2272-5. PubMed ID: 7529253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
    Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
    J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
    Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
    J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
    Bukh J; Miller RH
    Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
    Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
    Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.